British drug maker GlaxoSmithKline (GSK) is set to seek regulatory approval for the world’s first malaria vaccine after trials with the drug caused a 50 percent drop in the number of malaria cases in African children.
The vaccine is called RTS,S and was developed by GSK along with the non-profit Path Malaria Vaccine Initiative, with funding from the Bill and Melinda Gates Foundation. The vaccine has been in development by GSK for three decades and the trial was the largest-ever clinical trial conducted in Africa, involving almost 15,500 children across seven countries, the BBC reports.
The nearly 50 percent drop in childhood malaria cases, while dramatic, traditionally wouldn’t make a vaccine a sure thing, as most childhood vaccines provide at least 90 percent protection, according to NBC News.
Hmmm…I wonder if there is anything out there that does have a 90 percent success rate fighting this killer?
The enviro whackos have been willing to let over half a million kids-and a million people total-die annually for fifty years to save a few birds.
But don’t call them fanatics.
These are the same people who say that all anthropogenic global warming skeptics are “anti-science” although they’ve been eschewing science in favor of 4th Century BC netting technology.
Join the conversation as a VIP Member